BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30829551)

  • 1. Intraperitoneal perfusion chemotherapy and whole abdominal hyperthermia using external radiofrequency following radical D2 resection for treatment of advanced gastric cancer.
    Zhu L; Xu Y; Shan Y; Zheng R; Wu Z; Ma S
    Int J Hyperthermia; 2019; 36(1):403-407. PubMed ID: 30829551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study.
    Zhu L; Xu Z; Wu Y; Liu P; Qian J; Yu S; Xia B; Lai J; Ma S; Wu Z
    BMC Cancer; 2020 Aug; 20(1):827. PubMed ID: 32867714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
    BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anaesthesia and intensive care during intraoperative intraperitoneal hyperthermic chemotherapy in patients with gastric cancer (literature review and own clinical experience)].
    Khoronenko VE; Shemetova MM; Drozhzhina OV; Khomyakov VM; Sobolev DD
    Anesteziol Reanimatol; 2015; 60(1):50-4. PubMed ID: 26027226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer.
    Nomura E; Niki M; Fujii K; Shinohara H; Nishiguchi K; Sonoda T; Tanigawa N
    Gastric Cancer; 2001; 4(2):75-82. PubMed ID: 11706764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer].
    Wei G; Fang GE; Bi JW; Shen XJ; Nie MM; Xue XC; Hua JD
    Ai Zheng; 2005 Apr; 24(4):478-82. PubMed ID: 15820074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
    Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C
    Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.
    Hosoda K; Azuma M; Katada C; Moriya H; Mieno H; Ishido K; Ema A; Ushiku H; Wada T; Washio M; Watanabe A; Higuchi K; Tanabe S; Koizumi W; Watanabe M; Yamashita K
    Gastric Cancer; 2019 May; 22(3):598-606. PubMed ID: 30284080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer].
    Sugiyama Y; Suzuki H; Hada R; Miyagishima K; Yokoyama M; Daidouji K; Murata A; Yamazaki S; Mikami Y; Ozawa M
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):619-24. PubMed ID: 1901477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
    Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study.
    Kim IH; Park SS; Lee CM; Kim MC; Kwon IK; Min JS; Kim HI; Lee HH; Lee SI; Chae H
    Ann Surg Oncol; 2018 May; 25(5):1176-1183. PubMed ID: 29450755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion.
    Kang LY; Mok KT; Liu SI; Tsai CC; Wang BW; Chen IS; Chen YC; Chang BM; Chou NH
    J Chin Med Assoc; 2013 Aug; 76(8):425-31. PubMed ID: 23796652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.
    Saladino E; Fleres F; Mazzeo C; Pruiti V; Scollica M; Rossitto M; Cucinotta E; Macrì A
    Anticancer Res; 2014 Apr; 34(4):2019-22. PubMed ID: 24692741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites.
    Lu C; Li L; Luo Z; Cui Y; Fu P; Zhou J; Ma N; Zhou Y
    Neoplasma; 2016; 63(2):299-303. PubMed ID: 26774152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.